Send me a link:

*Text messaging rates may apply.

 Dow Down0.02% Nasdaq Down0.04%

PerkinElmer Inc. (PKI)

-NYSE
47.72 Up 0.07(0.15%) 4:02PM EDT
|After Hours : 47.72 0.00 (0.00%) 4:37PM EDT
ProfileGet Profile for:
PerkinElmer Inc.
940 Winter Street
Waltham, MA 02451
United States - Map
Phone: 781-663-6900
Website: http://www.perkinelmer.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Laboratories & Research
Full Time Employees:7,583

Business Summary 

PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates through two segments, Human Health and Environmental Health. The Human Health segment develops diagnostics, tools, and applications to help detect diseases earlier, and to accelerates the discovery and development of critical new therapies. This segment provides early detection for genetic disorders from pre-conception to early childhood, as well as offers digital x-ray flat panel detectors and infectious disease testing for the diagnostics market; and a suite of solutions, such as reagents, liquid handling, and detection and imaging technologies that enable researchers to improve the drug discovery process. Its research portfolio includes instrumentation for automation and detection solutions, in vitro and in vivo imaging and analysis hardware and software, and a portfolio of consumable products, including drug discovery and research reagents. The Environmental Health segment provides services and solutions to facilitate the creation of safer food and consumer products, secure surroundings, and efficient energy resources. This segment offers analytical technologies, solutions, and services that enable its customers to understand the health aspects of environment, including air, water, soil, and food; analytical instrumentation for the industrial market that comprise the chemical, petrochemical, lubricant, electronics, semiconductor, and quality assurance industries; and laboratory services. The company markets its products and services under various brands directly through its own sales force. Its customers include pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1931 and is headquartered in Waltham, Massachusetts.

Key Statistics


Company Websites 
Home Page
Subsidiaries
Divisions
Search Yahoo! for:
More on PerkinElmer Inc.

Corporate Governance 
PerkinElmer Inc.’s ISS Governance QuickScore as of Jul 1, 2014 is 6. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 7; Compensation: 7.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Robert F. Friel , 58
Chairman, Chief Exec. Officer, Pres and Member of Fin. Committee
3.23M4.50M
Mr. Frank A. Wilson , 55
Chief Financial Officer and Sr. VP
1.08M0.00
Dr. Daniel R. Marshak Ph.D., 56
Chief Scientific Officer and Sr. VP
877.00K418.00K
Mr. Joel S. Goldberg , 45
Sr. VP, Gen. Counsel and Sec.
909.00K0.00
Mr. James Corbett , 51
Pres of Human Health
671.00K0.00
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders